BNP PARIBAS ASSET MANAGEMENT Holding S.A.

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1520354 Paris, I0

Position in XENE

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$78,038,926

+$30,519,821 QoQ

Shares Held

1,342,028

+26.6% QoQ

Ownership

1.39%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $2,095,517,669 across 139 Biotechnology names. XENE ranks #6 (3.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	848,047	$378,686,906
2	REGN	Regeneron Pharmaceuticals, Inc.	273,120	$211,023,436
3	JAZZ	Jazz Pharmaceuticals plc	885,201	$167,347,247
4	ARGX	Argenx SE	129,147	$94,309,595
5	INCY	Incyte Corp	938,848	$88,364,372
6	XENE	Xenon Pharmaceuticals Inc. This page	1,342,028	$78,038,926
7	INSM	INSMED Inc	467,753	$76,486,969
8	IONS	Ionis Pharmaceuticals Inc	907,533	$68,146,652

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$78,038,926	1,342,028	+26.6%	Shares	Defined	2026-05-14
2025-12-31	$47,519,105	1,060,221	+58.2%	Shares	Defined	2026-02-13
2025-09-30	$26,910,817	670,257	+1.4%	Shares	Defined	2025-11-07
2025-06-30	$20,691,866	661,082	-6.1%	Shares	Defined	2025-08-06
2025-03-31	$23,612,322	703,795	+6.0%	Shares	Defined	2025-05-14
2024-12-31	$26,017,196	663,704	+51.2%	Shares	Defined	2025-02-12
2024-09-30	$17,286,342	439,074	+4.3%	Shares	Defined	2024-11-08
2024-06-30	$16,419,507	421,121	+1.1%	Shares	Defined	2024-07-30
2024-03-31	$17,940,484	416,736	—	Shares	Defined	2024-05-08
No filing history on record for this holder in this stock.